Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Ongoing studies investigating combinatorial regimens.
| Combinations | Clinical trials | Population |
|---|---|---|
| Mosunetuzumab + polatuzumab vedotin + obinutuzumab | NCT05169658 | Untreated indolent B‐cell lymphomas |
| Tazemetostat + mosunetuzumab | NCT05994235 | Newly diagnosed follicular lymphoma |
| Glofitamab + obinutuzumab | NCT05783596 | Untreated follicular lymphoma |
| Mosunetuzumab + lenalidomide | NCT04712097 | Relapsed follicular lymphoma |
